Global Nuclear Receptor ROR-Gamma Market Growth (Status and Outlook) 2022-2028
- LP 4929141
- 120 Pages
- March 2022
- Pharmaceuticals
The United States Nuclear Receptor ROR-Gamma market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Nuclear Receptor ROR-Gamma market, reaching US$ million by the year 2028. As for the Europe Nuclear Receptor ROR-Gamma landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Nuclear Receptor ROR-Gamma players cover 4SC AG, Advinus Therapeutics Ltd., Arrien Pharmaceuticals, LLC, and Aurigene Discovery Technologies Limited, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Nuclear Receptor ROR-Gamma market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
VPR-66
INV-17
GSK-2981278
BBI-6000
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital
Clinic
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
4SC AG
Advinus Therapeutics Ltd.
Arrien Pharmaceuticals, LLC
Aurigene Discovery Technologies Limited
Biogen, Inc.
Brickell Biotech, Inc.
Bristol-Myers Squibb Company
Celgene Corporation
Genentech, Inc.
Genfit SA
GlaxoSmithKline Plc
Hanmi Pharmaceuticals, Co. Ltd.
Karo Bio AB
Lead Pharma Holding B.V.
Nuevolution AB
Phenex Pharmaceuticals AG
Reata Pharmaceuticals, Inc.
Teijin Pharma Limited
Visionary Pharmaceuticals, Inc.
Vitae Pharmaceuticals, Inc.
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nuclear Receptor ROR-Gamma Market Size 2017-2028
2.1.2 Nuclear Receptor ROR-Gamma Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Nuclear Receptor ROR-Gamma Segment by Type
2.2.1 VPR-66
2.2.2 INV-17
2.2.3 GSK-2981278
2.2.4 BBI-6000
2.2.5 Others
2.3 Nuclear Receptor ROR-Gamma Market Size by Type
2.3.1 Nuclear Receptor ROR-Gamma Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Nuclear Receptor ROR-Gamma Market Size Market Share by Type (2017-2022)
2.4 Nuclear Receptor ROR-Gamma Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Nuclear Receptor ROR-Gamma Market Size by Application
2.5.1 Nuclear Receptor ROR-Gamma Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Nuclear Receptor ROR-Gamma Market Size Market Share by Application (2017-2022)
3 Nuclear Receptor ROR-Gamma Market Size by Player
3.1 Nuclear Receptor ROR-Gamma Market Size Market Share by Players
3.1.1 Global Nuclear Receptor ROR-Gamma Revenue by Players (2020-2022)
3.1.2 Global Nuclear Receptor ROR-Gamma Revenue Market Share by Players (2020-2022)
3.2 Global Nuclear Receptor ROR-Gamma Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Nuclear Receptor ROR-Gamma by Regions
4.1 Nuclear Receptor ROR-Gamma Market Size by Regions (2017-2022)
4.2 Americas Nuclear Receptor ROR-Gamma Market Size Growth (2017-2022)
4.3 APAC Nuclear Receptor ROR-Gamma Market Size Growth (2017-2022)
4.4 Europe Nuclear Receptor ROR-Gamma Market Size Growth (2017-2022)
4.5 Middle East & Africa Nuclear Receptor ROR-Gamma Market Size Growth (2017-2022)
5 Americas
5.1 Americas Nuclear Receptor ROR-Gamma Market Size by Country (2017-2022)
5.2 Americas Nuclear Receptor ROR-Gamma Market Size by Type (2017-2022)
5.3 Americas Nuclear Receptor ROR-Gamma Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nuclear Receptor ROR-Gamma Market Size by Region (2017-2022)
6.2 APAC Nuclear Receptor ROR-Gamma Market Size by Type (2017-2022)
6.3 APAC Nuclear Receptor ROR-Gamma Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Nuclear Receptor ROR-Gamma by Country (2017-2022)
7.2 Europe Nuclear Receptor ROR-Gamma Market Size by Type (2017-2022)
7.3 Europe Nuclear Receptor ROR-Gamma Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Nuclear Receptor ROR-Gamma by Region (2017-2022)
8.2 Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Type (2017-2022)
8.3 Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Nuclear Receptor ROR-Gamma Market Forecast
10.1 Global Nuclear Receptor ROR-Gamma Forecast by Regions (2023-2028)
10.1.1 Global Nuclear Receptor ROR-Gamma Forecast by Regions (2023-2028)
10.1.2 Americas Nuclear Receptor ROR-Gamma Forecast
10.1.3 APAC Nuclear Receptor ROR-Gamma Forecast
10.1.4 Europe Nuclear Receptor ROR-Gamma Forecast
10.1.5 Middle East & Africa Nuclear Receptor ROR-Gamma Forecast
10.2 Americas Nuclear Receptor ROR-Gamma Forecast by Country (2023-2028)
10.2.1 United States Nuclear Receptor ROR-Gamma Market Forecast
10.2.2 Canada Nuclear Receptor ROR-Gamma Market Forecast
10.2.3 Mexico Nuclear Receptor ROR-Gamma Market Forecast
10.2.4 Brazil Nuclear Receptor ROR-Gamma Market Forecast
10.3 APAC Nuclear Receptor ROR-Gamma Forecast by Region (2023-2028)
10.3.1 China Nuclear Receptor ROR-Gamma Market Forecast
10.3.2 Japan Nuclear Receptor ROR-Gamma Market Forecast
10.3.3 Korea Nuclear Receptor ROR-Gamma Market Forecast
10.3.4 Southeast Asia Nuclear Receptor ROR-Gamma Market Forecast
10.3.5 India Nuclear Receptor ROR-Gamma Market Forecast
10.3.6 Australia Nuclear Receptor ROR-Gamma Market Forecast
10.4 Europe Nuclear Receptor ROR-Gamma Forecast by Country (2023-2028)
10.4.1 Germany Nuclear Receptor ROR-Gamma Market Forecast
10.4.2 France Nuclear Receptor ROR-Gamma Market Forecast
10.4.3 UK Nuclear Receptor ROR-Gamma Market Forecast
10.4.4 Italy Nuclear Receptor ROR-Gamma Market Forecast
10.4.5 Russia Nuclear Receptor ROR-Gamma Market Forecast
10.5 Middle East & Africa Nuclear Receptor ROR-Gamma Forecast by Region (2023-2028)
10.5.1 Egypt Nuclear Receptor ROR-Gamma Market Forecast
10.5.2 South Africa Nuclear Receptor ROR-Gamma Market Forecast
10.5.3 Israel Nuclear Receptor ROR-Gamma Market Forecast
10.5.4 Turkey Nuclear Receptor ROR-Gamma Market Forecast
10.5.5 GCC Countries Nuclear Receptor ROR-Gamma Market Forecast
10.6 Global Nuclear Receptor ROR-Gamma Forecast by Type (2023-2028)
10.7 Global Nuclear Receptor ROR-Gamma Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 4SC AG
11.1.1 4SC AG Company Information
11.1.2 4SC AG Nuclear Receptor ROR-Gamma Product Offered
11.1.3 4SC AG Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 4SC AG Main Business Overview
11.1.5 4SC AG Latest Developments
11.2 Advinus Therapeutics Ltd.
11.2.1 Advinus Therapeutics Ltd. Company Information
11.2.2 Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Product Offered
11.2.3 Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Advinus Therapeutics Ltd. Main Business Overview
11.2.5 Advinus Therapeutics Ltd. Latest Developments
11.3 Arrien Pharmaceuticals, LLC
11.3.1 Arrien Pharmaceuticals, LLC Company Information
11.3.2 Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Product Offered
11.3.3 Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Arrien Pharmaceuticals, LLC Main Business Overview
11.3.5 Arrien Pharmaceuticals, LLC Latest Developments
11.4 Aurigene Discovery Technologies Limited
11.4.1 Aurigene Discovery Technologies Limited Company Information
11.4.2 Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Product Offered
11.4.3 Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Aurigene Discovery Technologies Limited Main Business Overview
11.4.5 Aurigene Discovery Technologies Limited Latest Developments
11.5 Biogen, Inc.
11.5.1 Biogen, Inc. Company Information
11.5.2 Biogen, Inc. Nuclear Receptor ROR-Gamma Product Offered
11.5.3 Biogen, Inc. Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Biogen, Inc. Main Business Overview
11.5.5 Biogen, Inc. Latest Developments
11.6 Brickell Biotech, Inc.
11.6.1 Brickell Biotech, Inc. Company Information
11.6.2 Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Product Offered
11.6.3 Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Brickell Biotech, Inc. Main Business Overview
11.6.5 Brickell Biotech, Inc. Latest Developments
11.7 Bristol-Myers Squibb Company
11.7.1 Bristol-Myers Squibb Company Company Information
11.7.2 Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Product Offered
11.7.3 Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Bristol-Myers Squibb Company Main Business Overview
11.7.5 Bristol-Myers Squibb Company Latest Developments
11.8 Celgene Corporation
11.8.1 Celgene Corporation Company Information
11.8.2 Celgene Corporation Nuclear Receptor ROR-Gamma Product Offered
11.8.3 Celgene Corporation Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Celgene Corporation Main Business Overview
11.8.5 Celgene Corporation Latest Developments
11.9 Genentech, Inc.
11.9.1 Genentech, Inc. Company Information
11.9.2 Genentech, Inc. Nuclear Receptor ROR-Gamma Product Offered
11.9.3 Genentech, Inc. Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Genentech, Inc. Main Business Overview
11.9.5 Genentech, Inc. Latest Developments
11.10 Genfit SA
11.10.1 Genfit SA Company Information
11.10.2 Genfit SA Nuclear Receptor ROR-Gamma Product Offered
11.10.3 Genfit SA Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Genfit SA Main Business Overview
11.10.5 Genfit SA Latest Developments
11.11 GlaxoSmithKline Plc
11.11.1 GlaxoSmithKline Plc Company Information
11.11.2 GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Product Offered
11.11.3 GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 GlaxoSmithKline Plc Main Business Overview
11.11.5 GlaxoSmithKline Plc Latest Developments
11.12 Hanmi Pharmaceuticals, Co. Ltd.
11.12.1 Hanmi Pharmaceuticals, Co. Ltd. Company Information
11.12.2 Hanmi Pharmaceuticals, Co. Ltd. Nuclear Receptor ROR-Gamma Product Offered
11.12.3 Hanmi Pharmaceuticals, Co. Ltd. Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Hanmi Pharmaceuticals, Co. Ltd. Main Business Overview
11.12.5 Hanmi Pharmaceuticals, Co. Ltd. Latest Developments
11.13 Karo Bio AB
11.13.1 Karo Bio AB Company Information
11.13.2 Karo Bio AB Nuclear Receptor ROR-Gamma Product Offered
11.13.3 Karo Bio AB Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Karo Bio AB Main Business Overview
11.13.5 Karo Bio AB Latest Developments
11.14 Lead Pharma Holding B.V.
11.14.1 Lead Pharma Holding B.V. Company Information
11.14.2 Lead Pharma Holding B.V. Nuclear Receptor ROR-Gamma Product Offered
11.14.3 Lead Pharma Holding B.V. Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Lead Pharma Holding B.V. Main Business Overview
11.14.5 Lead Pharma Holding B.V. Latest Developments
11.15 Nuevolution AB
11.15.1 Nuevolution AB Company Information
11.15.2 Nuevolution AB Nuclear Receptor ROR-Gamma Product Offered
11.15.3 Nuevolution AB Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Nuevolution AB Main Business Overview
11.15.5 Nuevolution AB Latest Developments
11.16 Phenex Pharmaceuticals AG
11.16.1 Phenex Pharmaceuticals AG Company Information
11.16.2 Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Product Offered
11.16.3 Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Phenex Pharmaceuticals AG Main Business Overview
11.16.5 Phenex Pharmaceuticals AG Latest Developments
11.17 Reata Pharmaceuticals, Inc.
11.17.1 Reata Pharmaceuticals, Inc. Company Information
11.17.2 Reata Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product Offered
11.17.3 Reata Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Reata Pharmaceuticals, Inc. Main Business Overview
11.17.5 Reata Pharmaceuticals, Inc. Latest Developments
11.18 Teijin Pharma Limited
11.18.1 Teijin Pharma Limited Company Information
11.18.2 Teijin Pharma Limited Nuclear Receptor ROR-Gamma Product Offered
11.18.3 Teijin Pharma Limited Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 Teijin Pharma Limited Main Business Overview
11.18.5 Teijin Pharma Limited Latest Developments
11.19 Visionary Pharmaceuticals, Inc.
11.19.1 Visionary Pharmaceuticals, Inc. Company Information
11.19.2 Visionary Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product Offered
11.19.3 Visionary Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 Visionary Pharmaceuticals, Inc. Main Business Overview
11.19.5 Visionary Pharmaceuticals, Inc. Latest Developments
11.20 Vitae Pharmaceuticals, Inc.
11.20.1 Vitae Pharmaceuticals, Inc. Company Information
11.20.2 Vitae Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product Offered
11.20.3 Vitae Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2022)
11.20.4 Vitae Pharmaceuticals, Inc. Main Business Overview
11.20.5 Vitae Pharmaceuticals, Inc. Latest Developments
12 Research Findings and Conclusion
Table 1. Nuclear Receptor ROR-Gamma Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of VPR-66
Table 3. Major Players of INV-17
Table 4. Major Players of GSK-2981278
Table 5. Major Players of BBI-6000
Table 6. Major Players of Others
Table 7. Nuclear Receptor ROR-Gamma Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Nuclear Receptor ROR-Gamma Market Size by Type (2017-2022) & ($ Millions)
Table 9. Global Nuclear Receptor ROR-Gamma Market Size Market Share by Type (2017-2022)
Table 10. Nuclear Receptor ROR-Gamma Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 11. Global Nuclear Receptor ROR-Gamma Market Size by Application (2017-2022) & ($ Millions)
Table 12. Global Nuclear Receptor ROR-Gamma Market Size Market Share by Application (2017-2022)
Table 13. Global Nuclear Receptor ROR-Gamma Revenue by Players (2020-2022) & ($ Millions)
Table 14. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Player (2020-2022)
Table 15. Nuclear Receptor ROR-Gamma Key Players Head office and Products Offered
Table 16. Nuclear Receptor ROR-Gamma Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Nuclear Receptor ROR-Gamma Market Size by Regions 2017-2022 & ($ Millions)
Table 20. Global Nuclear Receptor ROR-Gamma Market Size Market Share by Regions (2017-2022)
Table 21. Americas Nuclear Receptor ROR-Gamma Market Size by Country (2017-2022) & ($ Millions)
Table 22. Americas Nuclear Receptor ROR-Gamma Market Size Market Share by Country (2017-2022)
Table 23. Americas Nuclear Receptor ROR-Gamma Market Size by Type (2017-2022) & ($ Millions)
Table 24. Americas Nuclear Receptor ROR-Gamma Market Size Market Share by Type (2017-2022)
Table 25. Americas Nuclear Receptor ROR-Gamma Market Size by Application (2017-2022) & ($ Millions)
Table 26. Americas Nuclear Receptor ROR-Gamma Market Size Market Share by Application (2017-2022)
Table 27. APAC Nuclear Receptor ROR-Gamma Market Size by Region (2017-2022) & ($ Millions)
Table 28. APAC Nuclear Receptor ROR-Gamma Market Size Market Share by Region (2017-2022)
Table 29. APAC Nuclear Receptor ROR-Gamma Market Size by Type (2017-2022) & ($ Millions)
Table 30. APAC Nuclear Receptor ROR-Gamma Market Size Market Share by Type (2017-2022)
Table 31. APAC Nuclear Receptor ROR-Gamma Market Size by Application (2017-2022) & ($ Millions)
Table 32. APAC Nuclear Receptor ROR-Gamma Market Size Market Share by Application (2017-2022)
Table 33. Europe Nuclear Receptor ROR-Gamma Market Size by Country (2017-2022) & ($ Millions)
Table 34. Europe Nuclear Receptor ROR-Gamma Market Size Market Share by Country (2017-2022)
Table 35. Europe Nuclear Receptor ROR-Gamma Market Size by Type (2017-2022) & ($ Millions)
Table 36. Europe Nuclear Receptor ROR-Gamma Market Size Market Share by Type (2017-2022)
Table 37. Europe Nuclear Receptor ROR-Gamma Market Size by Application (2017-2022) & ($ Millions)
Table 38. Europe Nuclear Receptor ROR-Gamma Market Size Market Share by Application (2017-2022)
Table 39. Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Region (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Nuclear Receptor ROR-Gamma Market Size Market Share by Region (2017-2022)
Table 41. Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Type (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Nuclear Receptor ROR-Gamma Market Size Market Share by Type (2017-2022)
Table 43. Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Application (2017-2022) & ($ Millions)
Table 44. Middle East & Africa Nuclear Receptor ROR-Gamma Market Size Market Share by Application (2017-2022)
Table 45. Key Market Drivers & Growth Opportunities of Nuclear Receptor ROR-Gamma
Table 46. Key Market Challenges & Risks of Nuclear Receptor ROR-Gamma
Table 47. Key Industry Trends of Nuclear Receptor ROR-Gamma
Table 48. Global Nuclear Receptor ROR-Gamma Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 49. Global Nuclear Receptor ROR-Gamma Market Size Market Share Forecast by Regions (2023-2028)
Table 50. Global Nuclear Receptor ROR-Gamma Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 51. Global Nuclear Receptor ROR-Gamma Market Size Market Share Forecast by Type (2023-2028)
Table 52. Global Nuclear Receptor ROR-Gamma Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 53. Global Nuclear Receptor ROR-Gamma Market Size Market Share Forecast by Application (2023-2028)
Table 54. 4SC AG Details, Company Type, Nuclear Receptor ROR-Gamma Area Served and Its Competitors
Table 55. 4SC AG Nuclear Receptor ROR-Gamma Product Offered
Table 56. 4SC AG Nuclear Receptor ROR-Gamma Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 57. 4SC AG Main Business
Table 58. 4SC AG Latest Developments
Table 59. Advinus Therapeutics Ltd. Details, Company Type, Nuclear Receptor ROR-Gamma Area Served and Its Competitors
Table 60. Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Product Offered
Table 61. Advinus Therapeutics Ltd. Main Business
Table 62. Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 63. Advinus Therapeutics Ltd. Latest Developments
Table 64. Arrien Pharmaceuticals, LLC Details, Company Type, Nuclear Receptor ROR-Gamma Area Served and Its Competitors
Table 65. Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Product Offered
Table 66. Arrien Pharmaceuticals, LLC Main Business
Table 67. Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 68. Arrien Pharmaceuticals, LLC Latest Developments
Table 69. Aurigene Discovery Technologies Limited Details, Company Type, Nuclear Receptor ROR-Gamma Area Served and Its Competitors
Table 70. Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Product Offered
Table 71. Aurigene Discovery Technologies Limited Main Business
Table 72. Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 73. Aurigene Discovery Technologies Limited Latest Developments
Table 74. Biogen, Inc. Details, Company Type, Nuclear Receptor ROR-Gamma Area Served and Its Competitors
Table 75. Biogen, Inc. Nuclear Receptor ROR-Gamma Product Offered
Table 76. Biogen, Inc. Main Business
Table 77. Biogen, Inc. Nuclear Receptor ROR-Gamma Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 78. Biogen, Inc. Latest Developments
Table 79. Brickell Biotech, Inc. Details, Company Type, Nuclear Receptor ROR-Gamma Area Served and Its Competitors
Table 80. Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Product Offered
Table 81. Brickell Biotech, Inc. Main Business
Table 82. Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 83. Brickell Biotech, Inc. Latest Developments
Table 84. Bristol-Myers Squibb Company Details, Company Type, Nuclear Receptor ROR-Gamma Area Served and Its Competitors
Table 85. Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Product Offered
Table 86. Bristol-Myers Squibb Company Main Business
Table 87. Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 88. Bristol-Myers Squibb Company Latest Developments
Table 89. Celgene Corporation Details, Company Type, Nuclear Receptor ROR-Gamma Area Served and Its Competitors
Table 90. Celgene Corporation Nuclear Receptor ROR-Gamma Product Offered
Table 91. Celgene Corporation Main Business
Table 92. Celgene Corporation Nuclear Receptor ROR-Gamma Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 93. Celgene Corporation Latest Developments
Table 94. Genentech, Inc. Details, Company Type, Nuclear Receptor ROR-Gamma Area Served and Its Competitors
Table 95. Genentech, Inc. Nuclear Receptor ROR-Gamma Product Offered
Table 96. Genentech, Inc. Main Business
Table 97. Genentech, Inc. Nuclear Receptor ROR-Gamma Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 98. Genentech, Inc. Latest Developments
Table 99. Genfit SA Details, Company Type, Nuclear Receptor ROR-Gamma Area Served and Its Competitors
Table 100. Genfit SA Nuclear Receptor ROR-Gamma Product Offered
Table 101. Genfit SA Main Business
Table 102. Genfit SA Nuclear Receptor ROR-Gamma Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 103. Genfit SA Latest Developments
Table 104. GlaxoSmithKline Plc Details, Company Type, Nuclear Receptor ROR-Gamma Area Served and Its Competitors
Table 105. GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Product Offered
Table 106. GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 107. GlaxoSmithKline Plc Main Business
Table 108. GlaxoSmithKline Plc Latest Developments
Table 109. Hanmi Pharmaceuticals, Co. Ltd. Details, Company Type, Nuclear Receptor ROR-Gamma Area Served and Its Competitors
Table 110. Hanmi Pharmaceuticals, Co. Ltd. Nuclear Receptor ROR-Gamma Product Offered
Table 111. Hanmi Pharmaceuticals, Co. Ltd. Main Business
Table 112. Hanmi Pharmaceuticals, Co. Ltd. Nuclear Receptor ROR-Gamma Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 113. Hanmi Pharmaceuticals, Co. Ltd. Latest Developments
Table 114. Karo Bio AB Details, Company Type, Nuclear Receptor ROR-Gamma Area Served and Its Competitors
Table 115. Karo Bio AB Nuclear Receptor ROR-Gamma Product Offered
Table 116. Karo Bio AB Main Business
Table 117. Karo Bio AB Nuclear Receptor ROR-Gamma Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 118. Karo Bio AB Latest Developments
Table 119. Lead Pharma Holding B.V. Details, Company Type, Nuclear Receptor ROR-Gamma Area Served and Its Competitors
Table 120. Lead Pharma Holding B.V. Nuclear Receptor ROR-Gamma Product Offered
Table 121. Lead Pharma Holding B.V. Main Business
Table 122. Lead Pharma Holding B.V. Nuclear Receptor ROR-Gamma Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 123. Lead Pharma Holding B.V. Latest Developments
Table 124. Nuevolution AB Details, Company Type, Nuclear Receptor ROR-Gamma Area Served and Its Competitors
Table 125. Nuevolution AB Nuclear Receptor ROR-Gamma Product Offered
Table 126. Nuevolution AB Main Business
Table 127. Nuevolution AB Nuclear Receptor ROR-Gamma Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 128. Nuevolution AB Latest Developments
Table 129. Phenex Pharmaceuticals AG Details, Company Type, Nuclear Receptor ROR-Gamma Area Served and Its Competitors
Table 130. Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Product Offered
Table 131. Phenex Pharmaceuticals AG Main Business
Table 132. Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 133. Phenex Pharmaceuticals AG Latest Developments
Table 134. Reata Pharmaceuticals, Inc. Details, Company Type, Nuclear Receptor ROR-Gamma Area Served and Its Competitors
Table 135. Reata Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product Offered
Table 136. Reata Pharmaceuticals, Inc. Main Business
Table 137. Reata Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 138. Reata Pharmaceuticals, Inc. Latest Developments
Table 139. Teijin Pharma Limited Details, Company Type, Nuclear Receptor ROR-Gamma Area Served and Its Competitors
Table 140. Teijin Pharma Limited Nuclear Receptor ROR-Gamma Product Offered
Table 141. Teijin Pharma Limited Main Business
Table 142. Teijin Pharma Limited Nuclear Receptor ROR-Gamma Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 143. Teijin Pharma Limited Latest Developments
Table 144. Visionary Pharmaceuticals, Inc. Details, Company Type, Nuclear Receptor ROR-Gamma Area Served and Its Competitors
Table 145. Visionary Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product Offered
Table 146. Visionary Pharmaceuticals, Inc. Main Business
Table 147. Visionary Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 148. Visionary Pharmaceuticals, Inc. Latest Developments
Table 149. Vitae Pharmaceuticals, Inc. Details, Company Type, Nuclear Receptor ROR-Gamma Area Served and Its Competitors
Table 150. Vitae Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product Offered
Table 151. Vitae Pharmaceuticals, Inc. Main Business
Table 152. Vitae Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 153. Vitae Pharmaceuticals, Inc. Latest Developments
List of Figures
Figure 1. Nuclear Receptor ROR-Gamma Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Nuclear Receptor ROR-Gamma Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Nuclear Receptor ROR-Gamma Market Size Market Share by Type in 2021
Figure 7. Nuclear Receptor ROR-Gamma in Hospital
Figure 8. Global Nuclear Receptor ROR-Gamma Market: Hospital (2017-2022) & ($ Millions)
Figure 9. Nuclear Receptor ROR-Gamma in Clinic
Figure 10. Global Nuclear Receptor ROR-Gamma Market: Clinic (2017-2022) & ($ Millions)
Figure 11. Nuclear Receptor ROR-Gamma in Others
Figure 12. Global Nuclear Receptor ROR-Gamma Market: Others (2017-2022) & ($ Millions)
Figure 13. Global Nuclear Receptor ROR-Gamma Market Size Market Share by Application in 2021
Figure 14. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Player in 2021
Figure 15. Global Nuclear Receptor ROR-Gamma Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Nuclear Receptor ROR-Gamma Market Size 2017-2022 ($ Millions)
Figure 17. APAC Nuclear Receptor ROR-Gamma Market Size 2017-2022 ($ Millions)
Figure 18. Europe Nuclear Receptor ROR-Gamma Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Nuclear Receptor ROR-Gamma Market Size 2017-2022 ($ Millions)
Figure 20. Americas Nuclear Receptor ROR-Gamma Value Market Share by Country in 2021
Figure 21. Americas Nuclear Receptor ROR-Gamma Consumption Market Share by Type in 2021
Figure 22. Americas Nuclear Receptor ROR-Gamma Market Size Market Share by Application in 2021
Figure 23. United States Nuclear Receptor ROR-Gamma Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Nuclear Receptor ROR-Gamma Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Nuclear Receptor ROR-Gamma Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Nuclear Receptor ROR-Gamma Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Nuclear Receptor ROR-Gamma Market Size Market Share by Region in 2021
Figure 28. APAC Nuclear Receptor ROR-Gamma Market Size Market Share by Application in 2021
Figure 29. China Nuclear Receptor ROR-Gamma Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Nuclear Receptor ROR-Gamma Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Nuclear Receptor ROR-Gamma Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Nuclear Receptor ROR-Gamma Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Nuclear Receptor ROR-Gamma Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Nuclear Receptor ROR-Gamma Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Nuclear Receptor ROR-Gamma Market Size Market Share by Country in 2021
Figure 36. Europe Nuclear Receptor ROR-Gamma Market Size Market Share by Type in 2021
Figure 37. Europe Nuclear Receptor ROR-Gamma Market Size Market Share by Application in 2021
Figure 38. Germany Nuclear Receptor ROR-Gamma Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Nuclear Receptor ROR-Gamma Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Nuclear Receptor ROR-Gamma Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Nuclear Receptor ROR-Gamma Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Nuclear Receptor ROR-Gamma Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Nuclear Receptor ROR-Gamma Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Nuclear Receptor ROR-Gamma Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Nuclear Receptor ROR-Gamma Market Size Market Share by Application in 2021
Figure 46. Egypt Nuclear Receptor ROR-Gamma Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Nuclear Receptor ROR-Gamma Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Nuclear Receptor ROR-Gamma Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Nuclear Receptor ROR-Gamma Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Nuclear Receptor ROR-Gamma Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Nuclear Receptor ROR-Gamma Market Size 2023-2028 ($ Millions)
Figure 52. APAC Nuclear Receptor ROR-Gamma Market Size 2023-2028 ($ Millions)
Figure 53. Europe Nuclear Receptor ROR-Gamma Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Nuclear Receptor ROR-Gamma Market Size 2023-2028 ($ Millions)
Figure 55. United States Nuclear Receptor ROR-Gamma Market Size 2023-2028 ($ Millions)
Figure 56. Canada Nuclear Receptor ROR-Gamma Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Nuclear Receptor ROR-Gamma Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Nuclear Receptor ROR-Gamma Market Size 2023-2028 ($ Millions)
Figure 59. China Nuclear Receptor ROR-Gamma Market Size 2023-2028 ($ Millions)
Figure 60. Japan Nuclear Receptor ROR-Gamma Market Size 2023-2028 ($ Millions)
Figure 61. Korea Nuclear Receptor ROR-Gamma Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Nuclear Receptor ROR-Gamma Market Size 2023-2028 ($ Millions)
Figure 63. India Nuclear Receptor ROR-Gamma Market Size 2023-2028 ($ Millions)
Figure 64. Australia Nuclear Receptor ROR-Gamma Market Size 2023-2028 ($ Millions)
Figure 65. Germany Nuclear Receptor ROR-Gamma Market Size 2023-2028 ($ Millions)
Figure 66. France Nuclear Receptor ROR-Gamma Market Size 2023-2028 ($ Millions)
Figure 67. UK Nuclear Receptor ROR-Gamma Market Size 2023-2028 ($ Millions)
Figure 68. Italy Nuclear Receptor ROR-Gamma Market Size 2023-2028 ($ Millions)
Figure 69. Russia Nuclear Receptor ROR-Gamma Market Size 2023-2028 ($ Millions)
Figure 70. Spain Nuclear Receptor ROR-Gamma Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Nuclear Receptor ROR-Gamma Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Nuclear Receptor ROR-Gamma Market Size 2023-2028 ($ Millions)
Figure 73. Israel Nuclear Receptor ROR-Gamma Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Nuclear Receptor ROR-Gamma Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Nuclear Receptor ROR-Gamma Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
